Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Three stocks making headlines today: JNJ, CTLT, LMT
04:47pm, Tuesday, 18'th Apr 2023
Aptus Capital Advisors' Dave Wagner joins 'Power Lunch' to discuss how to trade three stocks making headlines today: Johnson & Johnson, Catalent, and Lockheed Martin.
Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat
04:28pm, Tuesday, 18'th Apr 2023
J&J's unpopular Covid vaccine appeared to bear its last fruit during the first quarter, contributing $747 million in sales.
Johnson and Johnson Beats Estimates and Raises Guidance
03:58pm, Tuesday, 18'th Apr 2023
Johnson and Johnson JNJ reported Q1 2023 earnings on Tuesday, April 18 before the market opened. The report showed strong top and bottom-line growth, and with the reasonable valuation JNJ currentl
Johnson & Johnson's Dividend: 61 And Counting
03:52pm, Tuesday, 18'th Apr 2023
Johnson & Johnson's Dividend: 61 And Counting
J&J, Goldman stocks cut Dow's price by 68 points after earnings
03:00pm, Tuesday, 18'th Apr 2023
Shares of Johnson & Johnson JNJ, -2.36% and Goldman Sachs Group Inc. GS, -1.84% were the biggest drags on the Dow Jones Industrial Average DJIA, -0.03% , even as both companies reported first-quarter
Housing Data Muted but Decent; JNJ and BAC Beat on Q1 Earnings
12:12pm, Tuesday, 18'th Apr 2023
Fresh Q1 earnings reports from major household firms join housing data from last month ahead of today's open.
J&J (JNJ) Q1 Earnings & Sales Top, 2023 View Up, Stock Rises
12:12pm, Tuesday, 18'th Apr 2023
J&J (JNJ) beats estimates for first-quarter earnings and sales. It raises full-year sales and earnings guidance.
Building Permits Declined in March
12:12pm, Tuesday, 18'th Apr 2023
We've got a healthy amount of grist for the trading mill ahead of today's opening bell, with fresh Q1 earnings reports from major household firms joining housing data from last month. All major indice
J&J Q1 earnings: ‘we feel very good about 2023'
12:01pm, Tuesday, 18'th Apr 2023
Shares of Johnson & Johnson (NYSE: JNJ) opened down this morning after the consumer health and pharmaceutical company said it swung to a loss in its first financial quarter. What resulted in a loss th
Johnson & Johnson raises full-year guidance as it puts talc lawsuit claims behind it
10:12am, Tuesday, 18'th Apr 2023
Johnson & Johnson (NYSE:JNJ) has credited a positive start to its 2023 financial year to strong performances from its three business segments as it raised its full-year guidance. However, the health
Johnson & Johnson (JNJ) Q1 Earnings and Revenues Top Estimates
09:10am, Tuesday, 18'th Apr 2023
Johnson & Johnson (JNJ) came out with quarterly earnings of $2.68 per share, beating the Zacks Consensus Estimate of $2.51 per share. This compares to earnings of $2.67 per share a year ago.
Great scientific innovation continues to produce great financial results for our company: J&J CFO
09:05am, Tuesday, 18'th Apr 2023
Joseph Wolk, Johnson & Johnson CFO, joins 'Squawk Box' to discuss the company's quarterly earnings results, how much the business controls headwinds, and more.
J&J Stock Closes In On A Key Point After Quarterly Beat And Raise
09:01am, Tuesday, 18'th Apr 2023
Johnson & Johnson beat first-quarter expectations Tuesday and raised its full-year outlook. In response, JNJ stock edged higher.
These 10 Crummy Stocks Already Cost Investors $300 Billion
08:00am, Tuesday, 18'th Apr 2023
What's worse than missing out on the five stocks driving the entire S&P 500 this year? Owning the ones that are dragging it down.
Johnson & Johnson beats on earnings and revenue, raises full-year guidance
06:50am, Tuesday, 18'th Apr 2023
J&J, whose financial results are considered a bellwether for many health companies, said its first-quarter sales grew 5.6% over the same quarter last year.
